Unicycive Therapeutics, Inc.UNCYNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank86
3Y CAGR+18.4%
5Y CAGR+73.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+18.4%/yr
vs +111.4%/yr prior
5Y CAGR
+73.3%/yr
Recent deceleration
Acceleration
-93.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
15.6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $31.55M | -1.7% |
| 2024 | $32.12M | +49.7% |
| 2023 | $21.45M | +12.9% |
| 2022 | $19.00M | +111.7% |
| 2021 | $8.98M | +344.4% |
| 2020 | $2.02M | +2.9% |
| 2019 | $1.96M | +106.2% |
| 2018 | $952000.00 | - |